Special Issue "Guidelines and Evolving Concepts in the Diagnosis, Treatment and Management of Acute Coronary Syndrome (ACS)"
Deadline for manuscript submissions: closed (30 September 2021).
Interests: acute coronary syndrome; percutaneous coronary intervention (PCI); guidelines; oral anticoagulants (OAC); atrial fibrillation
Special Issues and Collections in MDPI journals
Interests: acute coronary syndrome; percutaneous coronary intervention (PCI); guidelines; dual antiplatelet therapy (DAPT); risk scores; high bleeding risk patients
Interests: acute coronary syndrome; percutaneous coronary intervention (PCI); carotid artery disease; peripheral artery disease; drug-eluting balloons; structural cardiac interventions
There has been considerable progress in the management of ACS over the last twenty years. The understanding of the pathophysiology of intracoronary thrombosis from plaque erosion or rupture has paved the way for the evaluation of potent antithrombotic agents in the setting of ACS. Progressive developments in techniques and technologies for percutaneous coronary intervention have dramatically improved procedural effectiveness and safety and patients’ outcomes. However, acute presentations of coronary artery disease and their late consequences remain a leading cause of morbidity and mortality. While guidelines issued by scientific societies 1) summarize and evaluate available evidence to facilitate clinicians in their decision making for daily practice and 2) provide quality indicators to evaluate the implementation of proposed recommendations, continuously evolving research introduces new diagnostic algorithms and challenges therapeutic concepts. The present Special Issue has been conceived to provide an overview of the latest evidence in the field of ACS, focusing on both diagnostic and therapeutic advances and highlighting their implications for patients’ prognosis. Therefore, we welcome the submission of review articles as well as original research papers dealing with the topics of diagnostic and therapeutic advances in patients with ACS.
Dr. Giuseppe Andò
Dr. Francesco Costa
Dr. Antonio Micari
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- percutaneous coronary intervention (PCI)
- high-sensitivity cardiac troponins
- cardiogenic shock
- ST-elevation myocardial infarction (STEMI)
- non-st-elevation acute coronary syndrome (NSTE-ACS)
- coronary artery disease
- dual antiplatelet therapy (DAPT)
- oral anticoagulants (OAC)
- atrial fibrillation